Chamow and Associates Revenue and Competitors
Estimated Revenue & Valuation
- Chamow and Associates's estimated annual revenue is currently $775k per year.
- Chamow and Associates's estimated revenue per employee is $155,000
Employee Data
- Chamow and Associates has 5 Employees.
- Chamow and Associates grew their employee count by 0% last year.
Chamow and Associates's People
Name | Title | Email/Phone |
---|---|---|
1 | Administrative Assistant | Reveal Email/Phone |
Chamow and Associates Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Chamow and Associates?
Chamow & Associates is a leading provider of consulting services to the biopharmaceutical industry. Established by Dr. Steven Chamow in 2008, Chamow & Associates provides expert advice and guidance on the phases – preclinical to commercial – and costs of biopharmaceutical product development. Our expert team focuses exclusively on CMC—chemistry, manufacturing and controls —and specifically on biotherapeutics, with a focus on monoclonal antibodies. Our services include the key areas of CMC: technical design for production of drug substance and drug product, formulation and delivery of drug product, quality control and quality assurance, regulatory compliance and filing, and coordination of CMC activities between ourselves, clients and vendors.
keywords:N/AN/A
Total Funding
5
Number of Employees
$775k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.1M | 5 | -17% | $9.3M |
#2 | $0.3M | 5 | -50% | N/A |
#3 | $0.4M | 5 | -29% | N/A |
#4 | $0.4M | 5 | 0% | N/A |
#5 | $0.4M | 5 | 0% | N/A |